Manmed Pharma Private Limited
About Manmed Pharma Private Limited
Data last updated:
Manmed Pharma Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2019PTC066513. Its GSTIN is 08AAMCM9820H1Z2 (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nicky Sankla and Mahendra Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – S/3 Gokuldham Residency Aaradhana Colony Near Lata Circle Jhotwara, Jaipur, Rajasthan, India – 302012.
As per the financials filed for FY 2025, the company reported a revenue of ₹15,591, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹1.42 Lakh and EBITDA of -₹92,812. Revenue has declined at a compounded annual rate (CAGR) of 57% over three years and 34% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE – S/3 Gokuldham Residency Aaradhana Colony Near Lata Circle Jhotwara, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Manmed Pharma Private Limited
The main business activity of Manmed Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Manmed Pharma Private Limited FY 2025 filings available
Manmed Pharma Private Limited reported revenue of ₹15,591 (down 96% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Manmed Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 34% over five years, including a 96% fall in the latest year. EBITDA fell 162% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Manmed Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹92,812 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.42 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Manmed Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Manmed Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Manmed Pharma Private Limited
Manmed Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chitra Dyeing and Procesing Private Limited | ₹15,600 (FY 2019) | •••• | •••• | -100.0% | •••• | Delhi, India |
| Adhunik Texfab Private Limited | ₹15,600 (FY 2025) | •••• | •••• | 49.0% | •••• | New Delhi, Delhi, India |
| Biometrica Solutions and Services Private Limited | ₹15,600 (FY 2016) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Vegivate Food Solutions Private Limited | ₹15,597 (FY 2025) | •••• | •••• | -52.0% | •••• | Delhi, India |
| Vyas Enterprises Private Limited | ₹15,595 (FY 2022) | •••• | •••• | -98.0% | •••• | New Delhi, Delhi, India |
| Manmed Pharma Private Limited this company | ₹15,591 (FY 2025) | •••• | •••• | -96.0% | •••• | Jaipur, Rajasthan, India |
| Toffini Kitchenate Private Limited | ₹15,575 (FY 2020) | •••• | •••• | -89.0% | •••• | Lucknow, Uttar Pradesh, India |
| Devpujan Vyapaar Private Limited | ₹15,569 (FY 2017) | •••• | •••• | 46.0% | •••• | Kolkata, West Bengal, India |
| Ember Energy Resources & Washery Private Limited | ₹15,567 (FY 2019) | •••• | •••• | -82.0% | •••• | Ranchi, Jharkhand, India |
| Alacris Research & Development Private Limited | ₹15,562 (FY 2021) | •••• | •••• | -95.0% | •••• | Halvad, Gujarat, India |
| Rarer Biotech Private Limited | ₹15,537 (FY 2024) | •••• | •••• | -93.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Manmed Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Manmed Pharma Private Limited
Manmed Pharma Private Limited is audited by R K S A & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R K S A & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Manmed Pharma Private Limited
Manmed Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nicky Sankla | Director | 03 Oct 2019 | 7 Years 0 Months | Current |
| Mahendra Kumar | Director | 22 Apr 2022 | 4 Years 5 Months | Current |
Ownership and Shareholding of Manmed Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Manmed Pharma Private Limited
Manmed Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Manmed Pharma Private Limited
Employment history and EPFO contributions of people linked to Manmed Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Manmed Pharma Private Limited
Manmed Pharma Private Limited has 12 board changes on record since 2019: 7 appointments and 5 cessations. The latest: Abhishek Nuwal ceased to be Director on 13 May 2022.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Manmed Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Manmed Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Manmed Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Manmed Pharma Private Limited
Manmed Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAMCM9820H1Z2 | Rajasthan | Active | 11 Nov 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Manmed Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manmed Pharma Private Limited
Manmed Pharma is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 October 2019 (7+ years old) and is registered under CIN U24100RJ2019PTC066513.
Manmed Pharma reported revenue of ₹15,591 for FY 2025 (down 96% YoY).
Manmed Pharma has 2 current directors:
- Nicky Sankla - Director
- Mahendra Kumar - Director
Manmed Pharma reported a net loss of ₹1.42 Lakh and EBITDA of -₹92,812 for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Manmed Pharma is -57% over three years and -34% over five years. In the latest year (FY 2025) revenue fell 96%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Manmed Pharma is 08AAMCM9820H1Z2, registered in Rajasthan.
The CIN (Corporate Identification Number) of Manmed Pharma is U24100RJ2019PTC066513. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Manmed Pharma was incorporated on 03 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Manmed Pharma by revenue are Chitra Dyeing and Procesing Private Limited, Adhunik Texfab Private Limited, Biometrica Solutions and Services Private Limited, Vegivate Food Solutions Private Limited, Vyas Enterprises Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Abhishek Nuwal ceased to be Director on 13 May 2022. Ashish Kumar Meena ceased to be Additional Director on 13 May 2022. Hemlata Sharma ceased to be Additional Director on 13 May 2022. Manmed Pharma has 12 board changes on record in total.
The registered office of Manmed Pharma is at E – S3 Gokuldham Residency Aaradhana Colony Near Lata Circle Jhotwara, Jaipur, Rajasthan, India – 302012.